Induced Pluripotent Stem Cell Market Grows with Regenerative Medicine Research and Drug Discovery Applications | Thermo Fisher Scientific Inc., REPROCELL Inc., FUJIFILM Cellular Dynamics

The global induced pluripotent stem cell (iPS Cell) market size reached US$ 1.98 Billion in 2024 from US$ 1.81 Billion in 2023 and is expected to reach US$ 4.66 Billion by 2033, growing at a CAGR of 10.1% during the forecast period 2025-2033.

Induced Pluripotent Stem Cell Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With expanding regenerative medicine applications, drug discovery uses, and government-funded research, the report delivers strategic insights for stakeholders from 2025 to 2033.

As of 2025, Exciting developments include the launch of a GMP-compliant iPSC line by Pluristyx in January 2025, ready for immediate therapeutic research, and the NIH backing increased iPSC-related investigations, cementing the U.S. as a key innovation hub.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/induced-pluripotent-stem-cell-market?ophp

iPSCs are artificially reprogrammed cells with the ability to differentiate into various cell types, offering vast potential in regenerative medicine, disease modeling, and drug discovery. The market is growing due to advances in cell reprogramming technologies, increasing stem cell research funding, and expanding therapeutic applications.

Induced Pluripotent Stem Cell Market Competitors Overview:

Thermo Fisher Scientific Inc., REPROCELL Inc., FUJIFILM Cellular Dynamics, Axol Bioscience Ltd., Evotec, Takara Bio Inc., Fate Therapeutics, BlueRock Therapeutics LP, Aspen Neuroscience, and Ncardia, among others.

Important Industry Updates of 2023, 2024 and 2025:

In June 2025, Pluristyx, a leading provider of tools and services for cell product development, announced the launch of its first-of-its-kind PluriForm Organoid Kit, a turnkey solution to eliminate critical bottlenecks in organoid research and allow scientists to rapidly and reliably make pluripotent aggregates using quality-assured, induced pluripotent stem cells (iPSCs). The kit saves weeks of cell culture work and eliminates variability in organoid manufacturing, allowing reproducible and iterative development and application of organoids.

In September 2024, FUJIFILM Cellular Dynamics, a leading global developer and manufacturer of human induced pluripotent stem cells (iPSCs), announced the global commercial launch of its human iPSC-derived iCell Sensory Neurons for scientists engaged in neuroscience research, drug discovery of novel pain medications, and analysis of neurotoxicity side effects.

Methodology and Scope

The Induced Pluripotent Stem Cell Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/induced-pluripotent-stem-cell-market?ophp

Induced Pluripotent Stem Cell Market Segments Overview:

By Type (Human iPSCs, Mouse iPSCs), By Application (Academic Research, Drug Development and Discovery, Toxicity Screening, Regenerative Medicine, Others)

Regional Overview for Induced Pluripotent Stem Cell Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=induced-pluripotent-stem-cell-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Induced Pluripotent Stem Cell market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Induced Pluripotent Stem Cell market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.